Anticoagulation monitoring in extracorporeal membrane oxygenation

Abstract

Get full access to this article

View all access options for this article.

References

Abrams

Combes

Brodie

. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 2014; 63: 2769–2778.

Wang

Yang

Wang

, et al. Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score. Crit Care 2019; 23: 11.

Millar

Fanning

McDonald

, et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care 2016; 20: 387.

Wang

Shao

Fan

, et al. Disseminated intravascular coagulation score is related to short-term mortality in patients undergoing venoarterial extracorporeal mem-brane oxygenation after cardiac surgery. ASAIO J. Epub ahead of print 11 January 2021. DOI: 10.1097/MAT.0000000000001333.

Atallah

Liebl

Fitousis

, et al. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients. Perfusion 2014; 29: 456–461.

Bembea

Annich

Rycus

, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med 2013; 14: e77–e84.

Delmas

Jacquemin

Vardon-Bounes

, et al. Anticoagulation monitoring under ECMO support: a comparative study between the activated coagulation time and the anti-xa activity assay. J Intensive Care Med 2020; 35: 679–686.

Willems

Roeleveld

Labarinas

, et al. Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis. Perfusion 2021; 36: 501–512.